A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells

The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA.
Cell (Impact Factor: 32.24). 11/2010; 143(4):527-39. DOI: 10.1016/j.cell.2010.10.016
Source: PubMed


Autism spectrum disorders (ASD) are complex neurodevelopmental diseases in which different combinations of genetic mutations may contribute to the phenotype. Using Rett syndrome (RTT) as an ASD genetic model, we developed a culture system using induced pluripotent stem cells (iPSCs) from RTT patients' fibroblasts. RTT patients' iPSCs are able to undergo X-inactivation and generate functional neurons. Neurons derived from RTT-iPSCs had fewer synapses, reduced spine density, smaller soma size, altered calcium signaling and electrophysiological defects when compared to controls. Our data uncovered early alterations in developing human RTT neurons. Finally, we used RTT neurons to test the effects of drugs in rescuing synaptic defects. Our data provide evidence of an unexplored developmental window, before disease onset, in RTT syndrome where potential therapies could be successfully employed. Our model recapitulates early stages of a human neurodevelopmental disease and represents a promising cellular tool for drug screening, diagnosis and personalized treatment.

Download full-text


Available from: Cassiano Carromeu,
  • Source
    • "Human NPC Derivation, Growth, and Nucleofection NPCs were differentiated from HUES6 cells through embryoid body and rosette generation and grown as previously described (Marchetto et al., 2010). Plasmid delivery into human NPCs was performed by nucleofection (Lonza/Amaxa Nucleofector, kit VPG-1005). "
    [Show abstract] [Hide abstract]
    ABSTRACT: LINE-1 retrotransposons are fast-evolving mobile genetic entities that play roles in gene regulation, pathological conditions, and evolution. Here, we show that the primate LINE-1 50UTR contains a pri- mate-specific open reading frame (ORF) in the anti- sense orientation that we named ORF0. The gene product of this ORF localizes to promyelocytic leuke- mia-adjacent nuclear bodies. ORF0 is present in more than 3,000 loci across human and chimpanzee genomes and has a promoter and a conserved strong Kozak sequence that supports translation. By virtue of containing two splice donor sites, ORF0 can also form fusion proteins with proximal exons. ORF0 transcripts are readily detected in induced pluripotent stem (iPS) cells from both pri- mate species. Capped and polyadenylated ORF0 mRNAs are present in the cytoplasm, and endoge- nous ORF0 peptides are identified upon proteomic analysis. Finally, ORF0 enhances LINE-1 mobility. Taken together, these results suggest a role for ORF0 in retrotransposon-mediated diversity.
    Cell 10/2015; 163(163):583-593. DOI:10.1016/j.cell.2015.09.025 · 32.24 Impact Factor
  • Source
    • "This includes modeling of neuropsychiatric conditions related to DISC1 mutations (Wen et al., 2014), Rett syndrome (Marchetto et al., 2010), Timothy syndrome (Paş ca et al., 2011), sporadic schizophrenia (Brennand et al., 2011) and Phelan–McDermid (PMD) syndrome (Shcheglovitov et al., 2013). These studies "
    [Show abstract] [Hide abstract]
    ABSTRACT: The human brain is arguably the most complex structure among living organisms. However, the specific mechanisms leading to this complexity remain incompletely understood, primarily because of the poor experimental accessibility of the human embryonic brain. Over recent years, technologies based on pluripotent stem cells (PSCs) have been developed to generate neural cells of various types. While the translational potential of PSC technologies for disease modeling and/or cell replacement therapies is usually put forward as a rationale for their utility, they are also opening novel windows for direct observation and experimentation of the basic mechanisms of human brain development. PSC-based studies have revealed that a number of cardinal features of neural ontogenesis are remarkably conserved in human models, which can be studied in a reductionist fashion. They have also revealed species-specific features, which constitute attractive lines of investigation to elucidate the mechanisms underlying the development of the human brain, and its link with evolution.
    Development 09/2015; 142(18):3138-3150. DOI:10.1242/dev.120568 · 6.46 Impact Factor
  • Source
    • "All three studies showed that neurons from Rett syndrome hiPSC-derived neurons recapitulated a hallmark feature of ASD, reduction in soma size. In addition, Marchetto et al. (2010) reported that Rett syndrome hiPSC-derived neurons had fewer synapses, reduced spine density and alterations in calcium signalling and defects in electrophysiology. Altered dendritic arborisation and synaptic density are characteristics that appear to be shared between ASD and SCZ. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Over recent years tremendous progress has been made towards understanding the molecular and cellular mechanism by which estrogens exert enhancing effects on cognition, and how they act as a neuroprotective or neurotrophic agent in disease. Currently, much of this work has been carried out in animal models with only a limited number of studies using native human tissue or cells. Recent advances in stem cell technology now make it possible to reprogram somatic cells from humans into induced pluripotent stem cells (iPSCs), which can subsequently be differentiated in neurons of specific lineages. Importantly, the reprogramming of cells allows for the generation of iPSCs that retains the genetic "makeup" of the donor. Therefore, it is possible to generate iPSC-derived neurons from patients diagnosed with specific diseases, that harbor the complex genetic background associated with the disorder. Here, we review the iPSC technology and how its currently being used to model neural development and neurological diseases. Furthermore, we explore whether this cellular system could be used to understand the role of estrogens in human neurons, and present preliminary data in support of this. We further suggest that the use of iPSC technology offers a novel system in which to not only further understand estrogens' effects in human cells, but in which to investigate the mechanism by which estrogens are beneficial in disease. Developing a greater understanding of these mechanisms in native human cells will also aid in the development of safer and more effective estrogen-based therapeutics. Copyright © 2015. Published by Elsevier Inc.
    Hormones and Behavior 07/2015; 26. DOI:10.1016/j.yhbeh.2015.06.014 · 4.63 Impact Factor
Show more